Research and development expenses were $7,000,000 compared to $5,500,000 in the prior year period and $4,700,000 in the prior quarter. Selling, general and administrative expenses were $2,700,000 in the quarter ended December 31, 2023 compared to $3,000,000 in the prior year quarter and $2,500,000 in the previous quarter. 3rd quarter fiscal 2024 operating loss was $6,700,000 compared to $4,800,000 in the prior year period and operating loss of $4,100,000 in the prior quarter. 3rd quarter fiscal 2024 net loss included net interest and other income $155,000 and a tax provision of $71,000 compared to net interest and other income of $61,000 and a tax provision of $84,000 for the same period a year ago. In the preceding second quarter, net loss included net interest and other income of $71,000 and a cash provision of $33,000 Total 3rd quarter pre tax stock based compensation expense was $649,000 compared to $655,000 in the comparable quarter a year ago and $676,000 in the prior quarter.